Thursday, September 07, 2017 9:47:05 PM
https://globenewswire.com/news-release/2017/07/17/1047374/0/en/PreveCeutical-signs-Research-and-Option-Agreement-with-UniQuest-Pty-Limited-for-Developing-Dual-Gene-Therapy-Treatment-for-Diabetes-and-Obesity.html
A Less Controversial Application For Gene Editing: Obesity And Diabetes
http://www.huffingtonpost.ca/jason-tetro/a-less-controversial-application-for-gene-editing-obesity-and-d_a_23074666/
Recent PRVCF News
- Dual Listed Biotech Begins to Prepare POC Preclinical Study for Diabetes & Obesity Dual Gene Therapy Program • AllPennyStocks.com • 12/04/2023 01:00:00 PM
- Dual Listed Biotech Begins to Prepare POC Preclinical Study for Diabetes & Obesity Dual Gene Therapy Program • AllPennyStocks.com • 12/04/2023 01:00:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM